Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
Related structures:
AlphaFold database: A4HD58
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006643 | membrane lipid metabolic process | 4 | 14 |
GO:0006665 | sphingolipid metabolic process | 4 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0008610 | lipid biosynthetic process | 4 | 14 |
GO:0009058 | biosynthetic process | 2 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 14 |
GO:0044255 | cellular lipid metabolic process | 3 | 14 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 14 |
GO:1901576 | organic substance biosynthetic process | 3 | 14 |
GO:0006672 | ceramide metabolic process | 4 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043603 | amide metabolic process | 3 | 2 |
GO:0043604 | amide biosynthetic process | 4 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046513 | ceramide biosynthetic process | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0016491 | oxidoreductase activity | 2 | 14 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 14 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 4 | 14 |
GO:0042284 | sphingolipid delta-4 desaturase activity | 5 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.238 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.304 |
CLV_PCSK_PC1ET2_1 | 321 | 323 | PF00082 | 0.318 |
CLV_PCSK_PC7_1 | 317 | 323 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.307 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.209 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.168 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.275 |
DOC_CKS1_1 | 47 | 52 | PF01111 | 0.341 |
DOC_CKS1_1 | 98 | 103 | PF01111 | 0.500 |
DOC_CYCLIN_RxL_1 | 155 | 163 | PF00134 | 0.288 |
DOC_CYCLIN_yCln2_LP_2 | 113 | 119 | PF00134 | 0.313 |
DOC_MAPK_gen_1 | 177 | 186 | PF00069 | 0.476 |
DOC_MAPK_MEF2A_6 | 46 | 54 | PF00069 | 0.308 |
DOC_MAPK_MEF2A_6 | 63 | 72 | PF00069 | 0.333 |
DOC_PP1_RVXF_1 | 130 | 137 | PF00149 | 0.291 |
DOC_PP1_RVXF_1 | 175 | 182 | PF00149 | 0.475 |
DOC_PP2B_LxvP_1 | 113 | 116 | PF13499 | 0.313 |
DOC_PP4_FxxP_1 | 98 | 101 | PF00568 | 0.510 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.341 |
DOC_WW_Pin1_4 | 97 | 102 | PF00397 | 0.500 |
LIG_14-3-3_CanoR_1 | 273 | 280 | PF00244 | 0.543 |
LIG_14-3-3_CanoR_1 | 290 | 295 | PF00244 | 0.544 |
LIG_AP2alpha_2 | 41 | 43 | PF02296 | 0.476 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.583 |
LIG_BRCT_BRCA1_1 | 229 | 233 | PF00533 | 0.523 |
LIG_CSL_BTD_1 | 42 | 45 | PF09270 | 0.383 |
LIG_eIF4E_1 | 155 | 161 | PF01652 | 0.288 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.307 |
LIG_FHA_1 | 192 | 198 | PF00498 | 0.299 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.320 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.329 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.451 |
LIG_FHA_2 | 143 | 149 | PF00498 | 0.263 |
LIG_FHA_2 | 295 | 301 | PF00498 | 0.468 |
LIG_FXI_DFP_1 | 263 | 267 | PF00024 | 0.242 |
LIG_HP1_1 | 50 | 54 | PF01393 | 0.156 |
LIG_KLC1_Yacidic_2 | 283 | 287 | PF13176 | 0.533 |
LIG_LIR_Apic_2 | 243 | 249 | PF02991 | 0.442 |
LIG_LIR_Gen_1 | 100 | 111 | PF02991 | 0.462 |
LIG_LIR_Gen_1 | 163 | 171 | PF02991 | 0.307 |
LIG_LIR_Gen_1 | 178 | 189 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 194 | 202 | PF02991 | 0.254 |
LIG_LIR_Gen_1 | 230 | 240 | PF02991 | 0.344 |
LIG_LIR_Gen_1 | 297 | 307 | PF02991 | 0.553 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 163 | 167 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 194 | 198 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 219 | 224 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 230 | 236 | PF02991 | 0.441 |
LIG_LIR_Nem_3 | 242 | 247 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 265 | 269 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 283 | 288 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 64 | 70 | PF02991 | 0.237 |
LIG_Pex14_1 | 206 | 210 | PF04695 | 0.291 |
LIG_Pex14_1 | 255 | 259 | PF04695 | 0.476 |
LIG_Pex14_2 | 164 | 168 | PF04695 | 0.304 |
LIG_Pex14_2 | 202 | 206 | PF04695 | 0.390 |
LIG_Pex14_2 | 212 | 216 | PF04695 | 0.402 |
LIG_Pex14_2 | 98 | 102 | PF04695 | 0.372 |
LIG_PTB_Apo_2 | 101 | 108 | PF02174 | 0.476 |
LIG_PTB_Apo_2 | 253 | 260 | PF02174 | 0.533 |
LIG_PTB_Phospho_1 | 101 | 107 | PF10480 | 0.491 |
LIG_PTB_Phospho_1 | 253 | 259 | PF10480 | 0.533 |
LIG_SH2_CRK | 119 | 123 | PF00017 | 0.156 |
LIG_SH2_CRK | 247 | 251 | PF00017 | 0.442 |
LIG_SH2_CRK | 310 | 314 | PF00017 | 0.410 |
LIG_SH2_NCK_1 | 119 | 123 | PF00017 | 0.156 |
LIG_SH2_PTP2 | 285 | 288 | PF00017 | 0.581 |
LIG_SH2_STAP1 | 107 | 111 | PF00017 | 0.333 |
LIG_SH2_STAP1 | 119 | 123 | PF00017 | 0.300 |
LIG_SH2_STAP1 | 310 | 314 | PF00017 | 0.489 |
LIG_SH2_STAT3 | 189 | 192 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.242 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.242 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.269 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.265 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.578 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.320 |
LIG_SH3_3 | 112 | 118 | PF00018 | 0.323 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.450 |
LIG_SH3_3 | 39 | 45 | PF00018 | 0.383 |
LIG_SUMO_SIM_anti_2 | 49 | 55 | PF11976 | 0.156 |
LIG_SUMO_SIM_anti_2 | 69 | 74 | PF11976 | 0.441 |
LIG_TRFH_1 | 301 | 305 | PF08558 | 0.568 |
LIG_TYR_ITIM | 117 | 122 | PF00017 | 0.156 |
LIG_TYR_ITIM | 208 | 213 | PF00017 | 0.363 |
LIG_WRC_WIRS_1 | 161 | 166 | PF05994 | 0.307 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.396 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.263 |
MOD_CMANNOS | 203 | 206 | PF00535 | 0.441 |
MOD_CMANNOS | 252 | 255 | PF00535 | 0.263 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.443 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.308 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.533 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.456 |
MOD_N-GLC_2 | 95 | 97 | PF02516 | 0.238 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.321 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.242 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.289 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.298 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.581 |
MOD_PIKK_1 | 142 | 148 | PF00454 | 0.144 |
MOD_PIKK_1 | 272 | 278 | PF00454 | 0.344 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.476 |
MOD_PKA_2 | 272 | 278 | PF00069 | 0.438 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.491 |
MOD_Plk_4 | 211 | 217 | PF00069 | 0.331 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.437 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.268 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.341 |
MOD_ProDKin_1 | 97 | 103 | PF00069 | 0.500 |
MOD_SUMO_for_1 | 179 | 182 | PF00179 | 0.533 |
MOD_SUMO_for_1 | 320 | 323 | PF00179 | 0.510 |
TRG_DiLeu_BaEn_2 | 230 | 236 | PF01217 | 0.438 |
TRG_DiLeu_BaLyEn_6 | 204 | 209 | PF01217 | 0.363 |
TRG_ENDOCYTIC_2 | 103 | 106 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.332 |
TRG_ENDOCYTIC_2 | 119 | 122 | PF00928 | 0.256 |
TRG_ENDOCYTIC_2 | 210 | 213 | PF00928 | 0.375 |
TRG_ENDOCYTIC_2 | 247 | 250 | PF00928 | 0.442 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.490 |
TRG_ENDOCYTIC_2 | 310 | 313 | PF00928 | 0.408 |
TRG_ER_diArg_1 | 21 | 24 | PF00400 | 0.362 |
TRG_Pf-PMV_PEXEL_1 | 132 | 137 | PF00026 | 0.491 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P225 | Leptomonas seymouri | 82% | 97% |
A0A0S4IWE2 | Bodo saltans | 52% | 100% |
A0A0S4IZS1 | Bodo saltans | 50% | 100% |
A0A1X0NG21 | Trypanosomatidae | 68% | 99% |
A0A1X0P7H0 | Trypanosomatidae | 68% | 99% |
A0A3S5H7G4 | Leishmania donovani | 85% | 100% |
A0A3S7WZX6 | Leishmania donovani | 85% | 100% |
A4I2A2 | Leishmania infantum | 84% | 95% |
C4R613 | Komagataella phaffii (strain GS115 / ATCC 20864) | 41% | 96% |
C9ZQX1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 99% |
E8NHH2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
E9AYE9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
G5EC63 | Caenorhabditis elegans | 43% | 95% |
O09005 | Mus musculus | 42% | 100% |
O15121 | Homo sapiens | 44% | 100% |
O44186 | Caenorhabditis elegans | 42% | 96% |
O59715 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 46% | 95% |
Q0II71 | Bos taurus | 44% | 100% |
Q3ZBY7 | Bos taurus | 43% | 100% |
Q4Q923 | Leishmania major | 85% | 100% |
Q4Q925 | Leishmania major | 85% | 100% |
Q564G3 | Rattus norvegicus | 42% | 100% |
Q5AJX2 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 43% | 93% |
Q5F3C1 | Gallus gallus | 40% | 100% |
Q5RE51 | Pongo abelii | 44% | 100% |
Q5XIF5 | Rattus norvegicus | 43% | 100% |
Q68FB8 | Xenopus tropicalis | 41% | 100% |
Q6H5U3 | Oryza sativa subsp. japonica | 45% | 100% |
Q6QHC5 | Homo sapiens | 44% | 100% |
Q6UQ04 | Microtus fortis | 41% | 100% |
Q8R2F2 | Mus musculus | 42% | 100% |
Q94515 | Drosophila melanogaster | 43% | 100% |
Q9ZPH4 | Arabidopsis thaliana | 43% | 100% |
V5DBA3 | Trypanosoma cruzi | 66% | 99% |